Insiders · Profile

Reitan Colleen F

Director at ALNYLAM PHARMACEUTICALS · Director at MYRIAD GENETICS. Filing since 29 Aug 2024. CIK 0001740730

Company
Date
Role
Action
Shares
Amount
Of holding
9 Sep 2025
Director
Sold on a plan
18,000
$8.42M
95.9%
16 Apr 2025
Director
Sold at will
36
$8.38K
100%
17 Oct 2024
Director
Bought
4
$1.21K
12.5%
3 Sep 2024
Director
Sold on a plan
46,012
$1.29M
52.0%
29 Aug 2024
Director
Bought
32
$9.15K
opened
5 decisions on file.